The University of Chicago Header Logo

Connection

Thomas Gajewski to Patient Safety

Back to Details
This is a "connection" page, showing publications Thomas Gajewski has written about Patient Safety.
Thomas Gajewski
Connection Strength
0.033
Patient Safety
  1. Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in BRAF-Mutant Melanoma. Clin Cancer Res. 2020 01 01; 26(1):46-53.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.